Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Coital Incontinence in Women With Urinary Incontinence: An International Study.

Illiano E, Mahfouz W, Giannitsas K, Kocjancic E, Vittorio B, Athanasopoulos A, Balsamo R, Natale F, Carbone A, Villari D, Filocamo MT, Finazzi Agrò E, Costantini E.

J Sex Med. 2018 Oct;15(10):1456-1462. doi: 10.1016/j.jsxm.2018.08.009. Epub 2018 Sep 20.

PMID:
30245022
2.

Urological dysfunction in young women: an inheritance of childhood?

Costantini E, Illiano E, Giannitsas K, Prestipino M, Pastore AL, Carbone A, Palleschi G, Balsamo R, Natale F, Villari D, Bini V, Maruccia S, Filocamo MT, Zucchi A.

BJU Int. 2018 Mar;121(3):453-457. doi: 10.1111/bju.14081. Epub 2017 Dec 21.

PMID:
29160004
3.

How to Deal with Pain Following a Vaginal Mesh Insertion.

Giannitsas K, Costantini E.

Eur Urol Focus. 2016 Aug;2(3):268-271. doi: 10.1016/j.euf.2016.04.011. Epub 2016 May 11.

PMID:
28723372
4.

The role of nonantibiotic treatment of community-acquired urinary tract infections.

Costantini E, Giannitsas K, Illiano E.

Curr Opin Urol. 2017 Mar;27(2):120-126. doi: 10.1097/MOU.0000000000000366. Review.

PMID:
27898456
5.

Reasons for and Against Use of Non-absorbable, Synthetic Mesh During Pelvic Organ Prolapse Repair, According to the Prolapsed Compartment.

Kontogiannis S, Goulimi E, Giannitsas K.

Adv Ther. 2017 Jan;33(12):2139-2149. Epub 2016 Oct 18. Review.

6.

Sacrocolpopexy for pelvic organ prolapse: evidence-based review and recommendations.

Costantini E, Brubaker L, Cervigni M, Matthews CA, O'Reilly BA, Rizk D, Giannitsas K, Maher CF.

Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:60-5. doi: 10.1016/j.ejogrb.2016.07.503. Epub 2016 Aug 3. Review.

PMID:
27566224
7.

Sacrocolpopexy for posthysterectomy vaginal vault prolapse: long-term follow-up.

Illiano E, Giannitsas K, Zucchi A, Di Biase M, Del Zingaro M, Bini V, Costantini E.

Int Urogynecol J. 2016 Oct;27(10):1563-9. doi: 10.1007/s00192-016-2998-4. Epub 2016 Mar 18.

PMID:
26992724
8.

Computed tomography cephalometric and upper airway measurements in patients with OSA and erectile dysfunction.

Drakatos P, Karkoulias K, Giannitsas K, Kalogeropoulou C, Papapanagiotou N, Lykouras D, Sampsonas F, Petsas T, Perimenis P, Spiropoulos K.

Sleep Breath. 2016 May;20(2):769-76. doi: 10.1007/s11325-015-1297-5. Epub 2016 Jan 15.

PMID:
26779901
9.

Intravesical Therapies for Radiation Cystitis.

Giannitsas K, Athanasopoulos A.

Curr Urol. 2015 Dec;8(4):169-174. doi: 10.1159/000365711. Epub 2015 Nov 10. Review.

10.

A review of cost-effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?

Giannitsas K, Athanasopoulos A.

Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):413-23. doi: 10.1586/14737167.2015.1011132. Epub 2015 Feb 6. Review.

PMID:
25656409
11.

Male overactive bladder: pharmacotherapy for the male.

Giannitsas K, Athanasopoulos A.

Curr Opin Urol. 2013 Nov;23(6):515-9. doi: 10.1097/MOU.0b013e328363fbf1. Review.

PMID:
23851386
12.

Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms.

Deirmentzoglou S, Giannitsas K, Perimenis P, Petsas T, Athanasopoulos A.

Urology. 2012 Jul;80(1):66-70. doi: 10.1016/j.urology.2012.04.023.

PMID:
22748866
13.

Versatility of the ventral approach in bulbar urethroplasty using dorsal, ventral or dorsal plus ventral oral grafts.

Palminteri E, Berdondini E, Fusco F, De Nunzio C, Giannitsas K, Shokeir AA.

Arab J Urol. 2012 Jun;10(2):118-24. doi: 10.1016/j.aju.2012.02.009. Epub 2012 Apr 20.

14.

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder.

Athanasopoulos A, Giannitsas K.

Adv Urol. 2011;2011:820816. doi: 10.1155/2011/820816. Epub 2011 Jun 7.

15.

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.

Sfoungaristos S, Giannitsas K, Perimenis P.

Expert Opin Pharmacother. 2011 Mar;12(4):533-47. doi: 10.1517/14656566.2011.524928. Review.

PMID:
21306289
16.

Preclinical compounds for the treatment of overactive bladder.

Giannitsas K, Konstantinopoulos A, Patsialas C, Athanasopoulos A, Perimenis P.

Expert Opin Ther Pat. 2009 Feb;19(2):107-17. doi: 10.1517/13543770802672606. Review.

PMID:
19441912
17.

The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction.

Konstantinopoulos A, Giannitsas K, Athanasopoulos A, Spathas D, Perimenis P.

Expert Opin Pharmacother. 2009 Feb;10(2):155-60. doi: 10.1517/14656560802678211 .

PMID:
19236190
18.

Effect of alfuzosin on female primary bladder neck obstruction.

Athanasopoulos A, Gyftopoulos K, Giannitsas K, Perimenis P.

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Feb;20(2):217-22. doi: 10.1007/s00192-008-0749-x. Epub 2008 Nov 4.

PMID:
18982236
19.

Safety of anticholinergics in patients with benign prostatic hyperplasia.

Athanasopoulos A, Mitropoulos D, Giannitsas K, Perimenis P.

Expert Opin Drug Saf. 2008 Jul;7(4):473-9. doi: 10.1517/14740338.7.4.473 . Review.

PMID:
18613810
20.

Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia.

Giannitsas K, Mitropoulos D, Konstantinopoulos A, Athanasopoulos A, Perimenis P.

Expert Opin Pharmacother. 2008 Jul;9(10):1687-93. doi: 10.1517/14656566.9.10.1687 . Review.

PMID:
18570602

Supplemental Content

Loading ...
Support Center